FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


16226 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Delta hepatitis viral agent Hepatitis D virus
Delta-9-tetrahydrocannabinol 27mg/mL/cannabinol 25mg/mL buccal spray Product containing precisely cannabidiol 25 milligram/1 milliliter and delta-9-tetrahydrocannabinol 27 milligram/1 milliliter conventional release oromucosal spray (clinical drug)
Demented relative Family history of dementia (situation)
Demineralization of enamel of teeth Incipient enamel caries
Demonstrates knowledge of traditional therapy Demonstrates knowledge of complementary therapy (finding)
Dendritic cell sarcoma, no International Classification of Diseases for Oncology subtype Dendritic cell sarcoma
Dendroaspis viridis Dendroaspis angusticeps
Dendrocygnini Subfamily Dendrocygninae (organism)
Dental disclosing agent Medicinal product categorised by therapeutic role
Dental disclosing preparation Medicinal product categorised by therapeutic role
Denver shunt Peritoneovenous shunt
Denver shunt patency test Peritoneovenous shunt patency test
Deoxycortisol Cortodoxone
Deoxycortisone Cortodoxone
Deoxyribonucleic acid of Aeromonas salmonicida Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of African swine fever virus Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Alcelaphine herpesvirus 1 Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Avipoxvirus Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Caprine arthritis encephalitis virus Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Capripoxvirus Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Cowdria ruminantium Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Equine herpesvirus 1 Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Equine herpesvirus 4 Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Feline herpesvirus 1 Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Lumpy skin disease virus Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Marek's disease virus Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Mycoplasma agalactiae Mycoplasma DNA
Deoxyribonucleic acid of Mycoplasma gallisepticum Mycoplasma DNA
Deoxyribonucleic acid of Ovine herpesvirus 2 Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Ovine progressive pneumonia virus Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Pseudorabies virus Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Taylorella equigenitalis Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Theileria mutans Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Theileria parva Deoxyribonucleic acid of microorganism (substance)
Deoxyribonucleic acid of Trypanosoma evansi Deoxyribonucleic acid of microorganism (substance)
Department of Health and Social Security (DHSS) medical examination NOS Specialized medical examination
Dependence caused by dissociative substance Hallucinogen dependence
Dependence on unknown drug Substance dependence (disorder)
Dependent territories of United Kingdom of Great Britain and Northern Ireland British Overseas Territories (geographic location)
Depo-provera injection given Injection of medroxyprogesterone acetate (procedure)
Depot contraceptive given Administration of depot contraceptive (procedure)
Depressor anguli oris flap Depressor anguli oris myocutaneous flap
Depth of cells in anterior chamber Depth of anterior chamber
Derangement of meniscus, NEC Derangement of meniscus
Dermatitis atrophicans Acrodermatitis atrophicans chronica
Dermatitis caused by drug AND/OR medicine taken internally Dermatitis caused by substance taken via oral route (disorder)
Dermatitis caused by substance taken internally Dermatitis caused by substance taken via oral route (disorder)
Dermatitis due to other specified substance taken internally Dermatitis caused by substance taken via oral route (disorder)
Dermatofibroma, no International Classification of Diseases for Oncology subtype Dermatofibroma (morphologic abnormality)
Dermatosis attributable to coumarin anticoagulant Dermatosis caused by coumarin (disorder)
Dermatosis of suspected viral etiology Suspected viral infection of skin (situation)
Dermatosis resulting from immunosuppressive therapy Dermatosis caused by immunosuppressant
Dermographism Dermatographic urticaria
Deroofing of cyst of organ NOC Surgical procedure (procedure)
Desflurane 99% liquid Product containing precisely desflurane 990 milligram/1 milliliter conventional release solution for inhalation (clinical drug)
Desloratadine 0.5mg/mL syrup Product containing precisely desloratadine 500 microgram/1 milliliter conventional release oral solution (clinical drug)
Desloratadine 2.5mg/pseudoephedrine 120mg m/r tablet Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
Desloratadine 2.5mg/pseudoephedrine 120mg prolonged-release oral tablet Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
Desloratadine 5mg/pseudoephedrine 240mg m/r tablet Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
Desloratadine 5mg/pseudoephedrine 240mg prolonged-release oral tablet Product containing only desloratadine and pseudoephedrine in oral dose form (medicinal product form)
Desmoplastic fibroma Desmoplastic fibroma
Desmoplastic juvenile ganglioglioma Desmoplastic infantile astrocytoma
Desmopressin acetate 0.01% solution Product containing only desmopressin (medicinal product)
Desoximetasone 0.5% gel Product containing only desoximetasone (medicinal product)
Destruction of intervertebral disc by other specified method Vertebral column destructive procedure
Destruction of lesion of organ NOC NOS Destruction of lesion
Destruction of lesion of organ NOC OS Destruction of lesion
Destruction of tissue of heart Catheter ablation of tissue of heart
Destruction of tissue of pharynx Pharynx destructive procedure
Destructive procedure of facial bone Facial bone destructive procedure
Destructive procedure on fetus to facilitate delivery Destruction of fetus
Desulfotomaculum orientis Desulfosporosinus orientis
Detachment of left retina co-occurrent with retinal defect Detachment of left retina with retinal break
Detachment of right retina co-occurrent with retinal defect Detachment of right retina with retinal break
Detection of poison Measurement of substance (procedure)
Detrusor hyperreflexia of bladder Neurogenic detrusor overactivity
Detrusor instability Idiopathic detrusor overactivity (disorder)
Detrusor instability Idiopathic detrusor overactivity (disorder)
Detrusor instability Idiopathic detrusor overactivity (disorder)
Detrusor instability of bladder Idiopathic detrusor overactivity (disorder)
Developmental handicap screening Screening for developmental disorder (procedure)
Dexamethasone 0.5mg/5mL elixir Dexamethasone 100 microgram/mL oral solution
Dexamethasone sodium phospha 0.05% Dexamethasone only product in ocular dose form
Dexamethasone sodium phosphate 0.05% conventional release eye drops Dexamethasone only product in ocular dose form
Dexamethasone sodium phosphate 0.05% single-use eye drops Dexamethasone only product in ocular dose form
Dexamethasone+hypromellose 0.1%/0.5% eye drops Dexamethasone 1 mg/mL and hypromellose 5 mg/mL eye solution
Dexamfetamine - non-pharmaceutical Dexamfetamine
Dexlansoprazole 30mg dual delayed-release oral capsule Dexlansoprazole 30 mg gastro-resistant oral capsule
Dexlansoprazole 30mg m/r capsule Dexlansoprazole 30 mg gastro-resistant oral capsule
Dexlansoprazole 60mg dual delayed-release oral capsule Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug)
Dexlansoprazole 60mg m/r capsule Product containing precisely dexlansoprazole 60 milligram/1 each gastro-resistant oral capsule (clinical drug)
Dexmethylphenidate 20mg m/r capsule Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug)
Dexmethylphenidate 20mg prolonged-release oral capsule Product containing precisely dexmethylphenidate hydrochloride 20 milligram/1 each prolonged-release oral capsule (clinical drug)
Dexmethylphenidate 5mg m/r capsule Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule
Dexmethylphenidate 5mg prolonged-release oral capsule Dexmethylphenidate hydrochloride 5 mg prolonged-release oral capsule
Dexon patch Prosthetic patch
Dexon suture Polyglycolic acid suture
Dexrazoxane hydrochloride Product containing dexrazoxane (medicinal product)
Dextran 40 (10%) injection solution 500mL bottle Dextran 40 100 mg/mL solution for injection
Dextran 40 10% injection Dextran 40 100 mg/mL solution for injection
Dextran 40/dextrose 5% infusion solution bag Dextran 40 100 mg/mL solution for injection

Start Previous Page 34 of 163 Next End


Reference Sets

Reference set descriptor

Back to Start